Mouse genetics has proven to be extremely valuable to biomedical research by permiting the investigator to examine the role of genes involved in a wide variety of disease processes and in validating or correcting the results of biochemical and molecular biology experiments. The ability to generate specific mutations in genes as well as conditional alleles of genes has greatly expanded the repetoire of transgenic and knockout model s available for study. To meet this ever-increasing demand for mouse models, DM ASS Medical School has an established Transgenic Animal Modeling Core. Since its inception in 1991, the mission of the Transgenic Animal Modeling Core is to produce genetically-altered mice for the UMASS Medical School community in a timely and cost-efficient manner. The size and scope of the Core was greatly expanded in 1997 and is now composed of two facilities, the Gene Targeting Facility- performing gene targeted ES cell work, and the Transgenic Mouse Facility, performing pronuclear injections, blastocyst injections, cryopreservation, and rederivation. In the last five years the Core has generated more than 250 different lines of transgenic mice, targeted over 40 genes in mouse ES cells, produced over 50 lines of gene-targeted mice via blastocyst injection, and has cryopreserved more than 35 lines of mice for UMASS researchers. In addition, the Core acts as a resource for information, protocols, and assistance for UMASS investigators working with genetically altered rodents and for those scientists performing ES cell work in their own labs. Furthermore, the Core now offers microinjection of DNA and lentiviral constructs into rat embryos in order to generate transgenic rats. Greater than 70% of all rodent models generated by the Transgenic Animal Modeling Core have been for UMASS DERC members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK032520-23
Application #
7311473
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
23
Fiscal Year
2006
Total Cost
$98,187
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Desai, Paurav B; San Agustin, Jovenal T; Stuck, Michael W et al. (2018) Ift25 is not a cystic kidney disease gene but is required for early steps of kidney development. Mech Dev 151:10-17
Ly, Socheata; Navaroli, Deanna M; Didiot, Marie-Cécile et al. (2017) Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Res 45:15-25
Wang, Feng; McCannell, Kurtis N; Boškovi?, Ana et al. (2017) Rlim-Dependent and -Independent Pathways for X Chromosome Inactivation in Female ESCs. Cell Rep 21:3691-3699
Watkin, Levi B; Mishra, Rabinarayan; Gil, Anna et al. (2017) Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol 140:1206-1210
LeBlanc, Scott E; Wu, Qiong; Lamba, Pallavi et al. (2016) Promoter-enhancer looping at the PPAR?2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucleic Acids Res 44:5133-47
Wang, Feng; Shin, JongDae; Shea, Jeremy M et al. (2016) Regulation of X-linked gene expression during early mouse development by Rlim. Elife 5:
Kincaid, Eleanor Z; Murata, Shigeo; Tanaka, Keiji et al. (2016) Specialized proteasome subunits have an essential role in the thymic selection of CD8(+) T cells. Nat Immunol 17:938-45
Townsley, E; O'Connor, G; Cosgrove, C et al. (2016) Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells. Clin Exp Immunol 183:419-30
Wyss, Lena; Stadinski, Brian D; King, Carolyn G et al. (2016) Affinity for self antigen selects Treg cells with distinct functional properties. Nat Immunol 17:1093-101
Delong, Thomas; Wiles, Timothy A; Baker, Rocky L et al. (2016) Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351:711-4

Showing the most recent 10 out of 707 publications